Uncaria rhynchophylla Inhibits the Production of Nitric Oxide and Interleukin-1β Through Blocking Nuclear Factor κB, Akt, and Mitogen-Activated Protein Kinase Activation in Macrophages

Journal of Medicinal Food

Volumn 13, Issue 5, 2010, Pages 1133-1140

  Kim, ji Hee ^a   Bae, Chang Hwan ^a   Park, Sun Young ^a   Lee, Sang Joon ^a   Kim, Younghee ^a  

^a Pusan National University   (South Korea)

Author keywords

Akt; inducible nitric oxide synthase; interleukin 1 ; mitogen activated protein kinases; nuclear factor B; Uncaria rhynchophylla

Indexed keywords

ANTIINFLAMMATORY AGENT; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NITRIC OXIDE; PLANT EXTRACT; PROTEIN KINASE B;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; MACROPHAGE; METABOLISM; MOUSE; PHYSIOLOGY; PLANT STEM; UNCARIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; ENZYME ACTIVATION; I-KAPPA B PROTEINS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; PLANT STEMS; PROTO-ONCOGENE PROTEINS C-AKT; UNCARIA;

EID: 79952115044     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.1128     Document Type: Article

References (53)

1. Hsieh C.L., Chen M.F., Li T.C., et al.: Anticonvulsant effect of Uncaria rhynchophylla (Miq) Jack. in rats with kainic acid-induced epileptic seizure. Am J Chin Med 1999;27:257-264
2. Matsumoto K, Morishige R, Murakami Y, et al.: Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies. Eur J Pharmacol 2005;517:191-199
3. Hu X.Y., Sun A.S., Sui YX: Effects of combined use of total alkaloids of Uncaria rhynchophylla and Coryadlis ambailis migo on cerebral ischemia-reperfusion injury in rats [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007;27:1007-1009
4. Lee J, Son D, Lee P, et al.: Protective effect of methanol extract of Uncaria rhynchophylla against excitotoxicity induced by N-methyl-d-aspartate in rat hippocampus. J Pharmacol Sci 2003;92:70-73
5. Liu W, Zhang Z.Q., Zhao X.M., Gao YS: Protective effect of Uncaria rhynchophylla total alkaloids pretreatment on hippocampal neurons after acute hypoxia [in Chinese]. Zhongguo Zhong Yao Za Zhi 2006;31:763-765
6. Ahn DK: Illustrated Book of Korean Medicinal Herbs. Kyohak Publishing Co., Seoul, 2003
7. Shi J.S., Yu J.X., Chen X.P., Xu RX: Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. Acta Pharmacol Sin 2003;24:97-101
8. Ozaki Y: Vasodilative effects of indole alkaloids obtained from domestic plants, Uncaria rhynchophylla Miq. and Amsonia elliptica Roem. et Schult. Nippon Yakurigaku Zasshi 1990;95:47-54
9. Zhang W.B., Chen C.X., Sim S.M., Kwan CY: In vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel). Naunyn Schmiedebergs Arch Pharmacol 2004;369:232-238
10. Suk K, Kim S.Y., Leem K, et al.: Neuroprotection by methanol extract of Uncaria rhynchophylla against global cerebral ischemia in rats. Life Sci 2002;70:2467-2480
11. Kuramochi T, Chu J, Suga T: Gou-teng (from Uncaria rhynchophylla Miquel)-induced endothelium-dependent and -independent relaxations in the isolated rat aorta. Life Sci 1994;54:2061-2069
12. Horie S, Yano S, Aimi N, Sakai S, Watanabe K: Effects of hirsutine, an antihypertensive indole alkaloid from Uncaria rhynchophylla, on intracellular calcium in rat thoracic aorta. Life Sci 1992;50:491-498
13. Lee J.S., Kim J, Kim B.Y., Lee H.S., Ahn J.S., Chang YS: Inhibition of phospholipase Vgamma1 and cancer cell proliferation by triterpene esters from Uncaria rhynchophylla. J Nat Prod 2000;63:753-756
14. Hsieh C.L., Tang N.Y., Chiang S.Y., Hsieh C.T., Lin JG: Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (MIQ) Jack and Gastrodia elata Bl., in kainic acid-treated rats. Life Sci 1999;65:2071-2082
15. Lin J.M., Lin C.C., Chen M.F., Ujiie T, Takada A: Studies on Taiwan folk medicine, thang-kau-tin (II): measurement of active oxygen scavenging activity using an ESR technique. Am J Chin Med 1995;23:43-51
16. Liu J, Mori A: Antioxidant and free radical scavenging activities of Gastrodia elata Bl. and Uncaria rhynchophylla (Miq.) Jacks. Neuropharmacology 1992;31:1287-1298
17. Kim D.Y., Jung J.A., Kim T.H., Seo S.W., Jung S.K., Park CS: Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice. J Ethnopharmacol 2009;122:567-572
18. Yuan D, Ma B, Wu C, et al.: Alkaloids from the leaves of Uncaria rhynchophylla and their inhibitory activity on NO production in lipopolysaccharide-activated microglia. J Nat Prod 2008;71:1271-1274
19. Yuan D, Ma B, Yang J.Y., et al.: Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism. Int Immunopharmacol 2009;9:1549-1554
20. Medzhitov R, Janeway CA Jr: Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997;91:295-298
21. Luscinskas F.W., Gimbrone MA Jr: Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. Annu Rev Med 1996;47:413-421
22. Diehl S, Rincon M: The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002;39:531-536
23. Mahida YR: The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000;6:21-33
24. Li Q, Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-734
25. Mercurio F, Manning AM: Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 1999;11:226-232
26. Cobb M.H., Goldsmith EJ: How MAP kinases are regulated. J Biol Chem 1995;270:14843-14846
27. Kim S.H., Kim J, Sharma RP: Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol Res 2004;49:433-439
28. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94
29. Schmidt HHHW, Kelm M: Determination of nitrite and nitrate by the Griess reaction. In: Methods in Nitric Oxide Research (Feelisch M, Stamler J, eds.). John Wiley & Sons, New York, 1996, pp. 491-497
30. Xie Q.W., Kashiwabara Y, Nathan C: Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase, J Biol Chem 1994;269:4705-4708
31. Lowenstein C.J., Alley E.W., Raval P, et al.: Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 1993;90:9730-9734
32. Lee J.C., Kumar S, Griswold D.E., Underwood D.C., Votta B.J., Adams JL: Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000;47:185-201
33. Xiao Z.Y., Zhou W.X., Zhang Y.X., et al.: Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation. Immunol Lett 2007;114:81-85
34. Dan H.C., Cooper M.J., Cogswell P.C., Duncan J.A., Ting J.P., Baldwin AS: Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK. Genes Dev 2008;22:1490-1500
35. Hattori Y, Hattori S, Kasai K: Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. Eur J Pharmacol 2003;481:153-158
36. Li X, Tupper J.C., Bannerman D.D., Winn R.K., Rhodes C.J., Harlan JM: Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun 2003;71:4414-4420
37. Madrid L.V., Mayo M.W., Reuther J.Y., Baldwin AS Jr: Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001;276:18934-18940
38. Minhajuddin M, Bijli K.M., Fazal F, et al.: Protein kinase C-δ and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-κB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. J Biol Chem 2009;284:4052-4061
39. Pelletier J.P., Jovanovic D, Fernandes J.C., et al.: Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-1286
40. Lohinai Z, Benedek P, Fehã©r E, et al.: Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123:353-360
41. Shin T, Tanuma N, Kim S, et al.: An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats. J Neuroimmunol 1998;92:133-138
42. Hua L.L., Liu J.S., Brosnan C.F., Lee SC: Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta: implications for multiple sclerosis. Ann Neurol 1998;43:384-387
43. Levy B, Valtier M, de Chillou C, Bollaert P.E., Cane D, Mallie JP: Beneficial effects of l-canavanine, a selective inhibitor of inducible nitric oxide synthase, on lactate metabolism and muscle high energy phosphates during endotoxic shock in rats. Shock 1999;11:98-103
44. Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., Christman JW: In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996;157:1630-1637
45. Pierce J.W., Schoenleber R, Jesmok G, et al.: Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997;272:21096-21103
46. Lewis A.J., Manning AM: New targets for anti-inflammatory drugs. Curr Opin Chem Biol 1999;3:489-494
47. Segain J.P., Raingeard, de la Bletiere D, et al.: Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut 2000;47:397-403
48. 2-terminal kinase. Eur J Pharmacol 2004;494:1-9
49. Kyriakis J.M., Avruch J: Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996;271:24313-24316
50. Ciallella J.R., Saporito M, Lund S, et al.: CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharide-treated cells and mice. Eur J Pharmacol 2005;515:179-187
51. Hemmings BA: Akt signaling: linking membrane events to life and death decisions. Science 1997;275:628-630
52. Kandel E.S., Hay N: The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999;253:210-229
53. Weichhart T, Saemann MD: The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 2008;67(Suppl 3):iii70-iii74